Improved Survival From Graft-versus-host Disease Following Pediatric Small Intestinal Transplantation Through Reduction in Systemic Immunosuppression Altering T-cell Chimerism Dynamics

Background. Graft-versus-host-disease (GvHD) is an infrequent but serious complication of small intestinal transplantation in children, which is associated with a very poor prognosis. This study evaluated a novel strategy of managing GvHD in these patients through a reduction in immunosuppression. M...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandeep Potluri, FRCPath, PhD, Sarah Lawson, FRCPath, Shyla Kishore, FRCPCH, Malobi Ogboli, FRCP, Jane Hartley, FRCPCH, Arun Alfred, FRCPath, Yvonne Wilson, FRCSG (Plast), Darius F. Mirza, FRCS, Khalid Sharif, FRCS, Girish Gupte, FRCPCH
Format: Article
Language:English
Published: Wolters Kluwer 2025-07-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001830
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849409108112834560
author Sandeep Potluri, FRCPath, PhD
Sarah Lawson, FRCPath
Shyla Kishore, FRCPCH
Malobi Ogboli, FRCP
Jane Hartley, FRCPCH
Arun Alfred, FRCPath
Yvonne Wilson, FRCSG (Plast)
Darius F. Mirza, FRCS
Khalid Sharif, FRCS
Girish Gupte, FRCPCH
author_facet Sandeep Potluri, FRCPath, PhD
Sarah Lawson, FRCPath
Shyla Kishore, FRCPCH
Malobi Ogboli, FRCP
Jane Hartley, FRCPCH
Arun Alfred, FRCPath
Yvonne Wilson, FRCSG (Plast)
Darius F. Mirza, FRCS
Khalid Sharif, FRCS
Girish Gupte, FRCPCH
author_sort Sandeep Potluri, FRCPath, PhD
collection DOAJ
description Background. Graft-versus-host-disease (GvHD) is an infrequent but serious complication of small intestinal transplantation in children, which is associated with a very poor prognosis. This study evaluated a novel strategy of managing GvHD in these patients through a reduction in immunosuppression. Methods. We conducted a retrospective review 108 consecutive pediatric patients at our center between 2005 and 2021, who had small intestinal transplantation. We assessed clinical features and outcomes as well as laboratory chimerism studies in cohorts of patients before and following a change in treatment strategy for GvHD from intensification to reduction in immunosuppression. Results. Fourteen percent of pediatric patients developed GvHD after small intestinal transplantation. A change in treatment strategy to a reduction in immunosuppression led to significantly improved overall survival (log rank P = 0.015). This improved survival correlated biologically with altered T-cell chimerism dynamics in blood; in patients who had a reduction in immunosuppression, there was abrogation of the rise in donor T-cell chimerism over time seen in the blood of patients who instead had intensification of their immunosuppression. This may be because of permitting recipient lymphocytes to have a host-versus-graft effect and outcompete donor-derived lymphocytes. Conclusions. Our results demonstrate that that altering the immunosuppressive therapy strategy, following clinical manifestations of GvHD such as a typical skin rash, from intensification to a reduction in immunosuppression led to significantly improved survival.
format Article
id doaj-art-d903d95ebb0841d6bd030656a8e8013b
institution Kabale University
issn 2373-8731
language English
publishDate 2025-07-01
publisher Wolters Kluwer
record_format Article
series Transplantation Direct
spelling doaj-art-d903d95ebb0841d6bd030656a8e8013b2025-08-20T03:35:36ZengWolters KluwerTransplantation Direct2373-87312025-07-01117e183010.1097/TXD.0000000000001830202507000-00007Improved Survival From Graft-versus-host Disease Following Pediatric Small Intestinal Transplantation Through Reduction in Systemic Immunosuppression Altering T-cell Chimerism DynamicsSandeep Potluri, FRCPath, PhD0Sarah Lawson, FRCPath1Shyla Kishore, FRCPCH2Malobi Ogboli, FRCP3Jane Hartley, FRCPCH4Arun Alfred, FRCPath5Yvonne Wilson, FRCSG (Plast)6Darius F. Mirza, FRCS7Khalid Sharif, FRCS8Girish Gupte, FRCPCH91 Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom.1 Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom.1 Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom.1 Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom.1 Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom.3 Department of Haematology, The Rotherham NHS Foundation Trust, Rotherham, United Kingdom.1 Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom.4 Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.1 Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom.1 Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom.Background. Graft-versus-host-disease (GvHD) is an infrequent but serious complication of small intestinal transplantation in children, which is associated with a very poor prognosis. This study evaluated a novel strategy of managing GvHD in these patients through a reduction in immunosuppression. Methods. We conducted a retrospective review 108 consecutive pediatric patients at our center between 2005 and 2021, who had small intestinal transplantation. We assessed clinical features and outcomes as well as laboratory chimerism studies in cohorts of patients before and following a change in treatment strategy for GvHD from intensification to reduction in immunosuppression. Results. Fourteen percent of pediatric patients developed GvHD after small intestinal transplantation. A change in treatment strategy to a reduction in immunosuppression led to significantly improved overall survival (log rank P = 0.015). This improved survival correlated biologically with altered T-cell chimerism dynamics in blood; in patients who had a reduction in immunosuppression, there was abrogation of the rise in donor T-cell chimerism over time seen in the blood of patients who instead had intensification of their immunosuppression. This may be because of permitting recipient lymphocytes to have a host-versus-graft effect and outcompete donor-derived lymphocytes. Conclusions. Our results demonstrate that that altering the immunosuppressive therapy strategy, following clinical manifestations of GvHD such as a typical skin rash, from intensification to a reduction in immunosuppression led to significantly improved survival.http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001830
spellingShingle Sandeep Potluri, FRCPath, PhD
Sarah Lawson, FRCPath
Shyla Kishore, FRCPCH
Malobi Ogboli, FRCP
Jane Hartley, FRCPCH
Arun Alfred, FRCPath
Yvonne Wilson, FRCSG (Plast)
Darius F. Mirza, FRCS
Khalid Sharif, FRCS
Girish Gupte, FRCPCH
Improved Survival From Graft-versus-host Disease Following Pediatric Small Intestinal Transplantation Through Reduction in Systemic Immunosuppression Altering T-cell Chimerism Dynamics
Transplantation Direct
title Improved Survival From Graft-versus-host Disease Following Pediatric Small Intestinal Transplantation Through Reduction in Systemic Immunosuppression Altering T-cell Chimerism Dynamics
title_full Improved Survival From Graft-versus-host Disease Following Pediatric Small Intestinal Transplantation Through Reduction in Systemic Immunosuppression Altering T-cell Chimerism Dynamics
title_fullStr Improved Survival From Graft-versus-host Disease Following Pediatric Small Intestinal Transplantation Through Reduction in Systemic Immunosuppression Altering T-cell Chimerism Dynamics
title_full_unstemmed Improved Survival From Graft-versus-host Disease Following Pediatric Small Intestinal Transplantation Through Reduction in Systemic Immunosuppression Altering T-cell Chimerism Dynamics
title_short Improved Survival From Graft-versus-host Disease Following Pediatric Small Intestinal Transplantation Through Reduction in Systemic Immunosuppression Altering T-cell Chimerism Dynamics
title_sort improved survival from graft versus host disease following pediatric small intestinal transplantation through reduction in systemic immunosuppression altering t cell chimerism dynamics
url http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001830
work_keys_str_mv AT sandeeppotlurifrcpathphd improvedsurvivalfromgraftversushostdiseasefollowingpediatricsmallintestinaltransplantationthroughreductioninsystemicimmunosuppressionalteringtcellchimerismdynamics
AT sarahlawsonfrcpath improvedsurvivalfromgraftversushostdiseasefollowingpediatricsmallintestinaltransplantationthroughreductioninsystemicimmunosuppressionalteringtcellchimerismdynamics
AT shylakishorefrcpch improvedsurvivalfromgraftversushostdiseasefollowingpediatricsmallintestinaltransplantationthroughreductioninsystemicimmunosuppressionalteringtcellchimerismdynamics
AT malobiogbolifrcp improvedsurvivalfromgraftversushostdiseasefollowingpediatricsmallintestinaltransplantationthroughreductioninsystemicimmunosuppressionalteringtcellchimerismdynamics
AT janehartleyfrcpch improvedsurvivalfromgraftversushostdiseasefollowingpediatricsmallintestinaltransplantationthroughreductioninsystemicimmunosuppressionalteringtcellchimerismdynamics
AT arunalfredfrcpath improvedsurvivalfromgraftversushostdiseasefollowingpediatricsmallintestinaltransplantationthroughreductioninsystemicimmunosuppressionalteringtcellchimerismdynamics
AT yvonnewilsonfrcsgplast improvedsurvivalfromgraftversushostdiseasefollowingpediatricsmallintestinaltransplantationthroughreductioninsystemicimmunosuppressionalteringtcellchimerismdynamics
AT dariusfmirzafrcs improvedsurvivalfromgraftversushostdiseasefollowingpediatricsmallintestinaltransplantationthroughreductioninsystemicimmunosuppressionalteringtcellchimerismdynamics
AT khalidshariffrcs improvedsurvivalfromgraftversushostdiseasefollowingpediatricsmallintestinaltransplantationthroughreductioninsystemicimmunosuppressionalteringtcellchimerismdynamics
AT girishguptefrcpch improvedsurvivalfromgraftversushostdiseasefollowingpediatricsmallintestinaltransplantationthroughreductioninsystemicimmunosuppressionalteringtcellchimerismdynamics